Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Enwave Corporation took a tumble today and lost -€0.006 (-4.350%).
Pros and Cons of Enwave Corporation in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -4.350% | -2.941% | -5.714% | -52.518% | -44.068% | -38.318% | -79.817% |
| Aurinia Pharmaceuticals Inc. | -1.620% | -6.846% | -12.521% | 63.913% | -3.526% | 16.652% | 10.832% |
| Spectral Medical Inc | 1.190% | -2.857% | 6.918% | 68.317% | 6.918% | 300.943% | 242.742% |
| Xenon Pharmaceuticals Inc. | - | -2.609% | 5.660% | 108.955% | 47.368% | 68.675% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license